Caseware UK (AP4) 2024.0.164 2024.0.164 2025-11-302025-11-30No description of principal activityfalse2024-12-01false55falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 08786525 2024-12-01 2025-11-30 08786525 2023-12-01 2024-11-30 08786525 2025-11-30 08786525 2024-11-30 08786525 c:Director5 2024-12-01 2025-11-30 08786525 d:PatentsTrademarksLicencesConcessionsSimilar 2025-11-30 08786525 d:PatentsTrademarksLicencesConcessionsSimilar 2024-11-30 08786525 d:CurrentFinancialInstruments 2025-11-30 08786525 d:CurrentFinancialInstruments 2024-11-30 08786525 d:CurrentFinancialInstruments d:WithinOneYear 2025-11-30 08786525 d:CurrentFinancialInstruments d:WithinOneYear 2024-11-30 08786525 d:ShareCapital 2025-11-30 08786525 d:ShareCapital 2024-11-30 08786525 d:RetainedEarningsAccumulatedLosses 2025-11-30 08786525 d:RetainedEarningsAccumulatedLosses 2024-11-30 08786525 c:FRS102 2024-12-01 2025-11-30 08786525 c:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 08786525 c:FullAccounts 2024-12-01 2025-11-30 08786525 c:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 08786525 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2024-12-01 2025-11-30 08786525 e:PoundSterling 2024-12-01 2025-11-30 iso4217:GBP xbrli:pure

Registered number: 08786525









COV-A-BLIND LTD







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2025

 
COV-A-BLIND LTD
REGISTERED NUMBER: 08786525

BALANCE SHEET
AS AT 30 NOVEMBER 2025

2025
2024
Note
£
£

Fixed assets
  

Intangible assets
 4 
2,266
2,610

Current assets
  

Stocks
  
91,208
92,221

Debtors: amounts falling due within one year
 5 
14,072
14,693

Cash at bank and in hand
  
2,401
9,517

  
107,681
116,431

Creditors: amounts falling due within one year
 6 
(161,088)
(162,969)

Net current liabilities
  
 
 
(53,407)
 
 
(46,538)

  

Net liabilities
  
(51,141)
(43,928)


Capital and reserves
  

Called up share capital 
  
3
3

Profit and loss account
  
(51,144)
(43,931)

  
(51,141)
(43,928)


Page 1

 
COV-A-BLIND LTD
REGISTERED NUMBER: 08786525
    
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 19 August 2026.




O Gualtieri
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
COV-A-BLIND LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025

1.


General information

Cov-A-Blind Ltd ("the Company") is a private company limited by shares, incorporated in England and Wales. Its registered office is 16 Lockfield Avenue, Enfield, England, EN3 7PX. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The Company continues to have the support of entities under common control and the accounts have therefore been prepared on the going concern basis.

 
2.3

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Statement of income and retained earnings except when deferred in other comprehensive income as qualifying cash flow hedges.

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Page 3

 
COV-A-BLIND LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025

2.Accounting policies (continued)

 
2.5

Finance costs

Finance costs are charged to the Statement of income and retained earnings over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.7

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis.

 
2.8

Debtors

Short term debtors are measured at transaction price, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. 

 
2.10

Creditors

Short term creditors are measured at the transaction price.


3.


Employees

The average monthly number of employees, including directors, during the year was 5 (2024 - 5).

Page 4

 
COV-A-BLIND LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025

4.


Intangible assets




Patents

£



Cost


At 1 December 2024
3,441



At 30 November 2025

3,441



Amortisation


At 1 December 2024
831


Charge for the year on owned assets
344



At 30 November 2025

1,175



Net book value



At 30 November 2025
2,266



At 30 November 2024
2,610




5.


Debtors

2025
2024
£
£


Trade debtors
354
220

Other debtors
13,718
14,473

14,072
14,693


Page 5

 
COV-A-BLIND LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025

6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
3,365
3,756

Other taxation and social security
-
274

Other creditors
156,023
157,239

Accruals and deferred income
1,700
1,700

161,088
162,969


 
Page 6